BR112021020951A2 - Dispensação e retenção de agentes ativos dentro da pele - Google Patents

Dispensação e retenção de agentes ativos dentro da pele

Info

Publication number
BR112021020951A2
BR112021020951A2 BR112021020951A BR112021020951A BR112021020951A2 BR 112021020951 A2 BR112021020951 A2 BR 112021020951A2 BR 112021020951 A BR112021020951 A BR 112021020951A BR 112021020951 A BR112021020951 A BR 112021020951A BR 112021020951 A2 BR112021020951 A2 BR 112021020951A2
Authority
BR
Brazil
Prior art keywords
skin
dispensing
retention
active agents
agents
Prior art date
Application number
BR112021020951A
Other languages
English (en)
Inventor
Douglas Levinson
R Vogus Douglas
Eric Spengler
Samir Mitragotri
Original Assignee
Fount Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fount Bio Inc filed Critical Fount Bio Inc
Publication of BR112021020951A2 publication Critical patent/BR112021020951A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

dispensação e retenção de agentes ativos dentro da pele. o presente pedido descreve a síntese, a formulação e os usos de sistemas compreendendo agentes capazes de penetrar na pele.
BR112021020951A 2019-04-19 2020-04-17 Dispensação e retenção de agentes ativos dentro da pele BR112021020951A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962836402P 2019-04-19 2019-04-19
PCT/US2020/028639 WO2020214889A1 (en) 2019-04-19 2020-04-17 Delivery and retention of active agents within the skin

Publications (1)

Publication Number Publication Date
BR112021020951A2 true BR112021020951A2 (pt) 2021-12-14

Family

ID=70617222

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021020951A BR112021020951A2 (pt) 2019-04-19 2020-04-17 Dispensação e retenção de agentes ativos dentro da pele

Country Status (8)

Country Link
US (1) US20220175819A1 (pt)
EP (1) EP3955887A1 (pt)
JP (1) JP2022531094A (pt)
KR (1) KR20220003557A (pt)
CN (1) CN113710225A (pt)
BR (1) BR112021020951A2 (pt)
CA (1) CA3133363A1 (pt)
WO (1) WO2020214889A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117551625B (zh) * 2024-01-12 2024-03-08 山东爱维德生物科技有限公司 一种用于木立芦荟sod胶的聚乙二醇二胺-海藻酸改性sod酶及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060008428A1 (en) 2004-06-16 2006-01-12 L'oreal Method of promoting the penetration of a cosmetic active and composition therefore
US8735386B2 (en) * 2010-07-23 2014-05-27 Boehringer Ingelheim International Gmbh Aminopyrazoloquinazolines
WO2012064429A2 (en) 2010-11-09 2012-05-18 The Regents Of The University Of California Skin permeating and cell entering (space) peptides and methods of use thereof
EP2719703A1 (en) * 2012-10-12 2014-04-16 Ecole Polytechnique Fédérale de Lausanne (EPFL) Precursor molecule for the synthesis of D-luciferin
WO2014178878A1 (en) * 2013-05-03 2014-11-06 Yale University Synthetic antibody mimetic compounds (syams) targeting cancer, especially prostate cancer
CA3118491A1 (en) * 2018-11-02 2020-05-07 Fount Bio, Inc. Crosslinked materials

Also Published As

Publication number Publication date
CA3133363A1 (en) 2020-10-22
KR20220003557A (ko) 2022-01-10
WO2020214889A1 (en) 2020-10-22
CN113710225A (zh) 2021-11-26
JP2022531094A (ja) 2022-07-06
EP3955887A1 (en) 2022-02-23
US20220175819A1 (en) 2022-06-09

Similar Documents

Publication Publication Date Title
ECSP19029982A (es) Moduladores de calpaínas y usos terapeuticos de los mismos
PH12018550062A1 (en) Topical film-forming spray
BR112017017448A2 (pt) métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho
BR112017006526A2 (pt) composição e kits para inibição de infecção microbiana patogênica e métodos de usar os mesmos
CL2020000220A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
MX2020001310A (es) Sistema aplicador que contiene una matriz de microagujas con un principio activo para la cicatrizacion.
BR112017005209A2 (pt) compostos moduladores de pirrolopiridina substituída por metila e trifluorometila de rorc2 e seu uso
BR112019024566A2 (pt) inibidores de pirazol magl
BR112017005282A2 (pt) produtos para tratamento de pele
BR112022012514A2 (pt) Formas de dosagem sólidas que contêm bactérias e vesículas extracelulares microbianas
MX2019014772A (es) Formulaciones en gel de bisfosfocinas y usos de estas.
CY1122310T1 (el) Εκχυλισμα γαρδενιας για τον χρωματισμο του δερματος
BR0207738A (pt) Sistema terapêutico transdermal altamente flex–vel com nicotina como subst ncia ativa
BR112021020951A2 (pt) Dispensação e retenção de agentes ativos dentro da pele
CL2019002516A1 (es) Composiciones cosméticas para el cuidado de la piel.
CL2020001738A1 (es) Preparación de absorción percutánea para el tratamiento de la demencia que contiene donepezilo.
MX2018003953A (es) Composiciones topicas que comprenden retinoides y agentes de limpieza polimericos de baja irritacion.
NI201900128A (es) Combinación de un inhibidor de mcl-1 y un tratamiento de atención estándar para cáncer hematológico, usos y composiciones farmacéuticas de esta
BR112018015031A2 (pt) formulação de cuidados pessoais, recipiente que contém uma formulação para cuidados pessoais, e método de umedecimento da pele ou dos cabelos em pacientes
BR112021000183A8 (pt) Preparação medicinal para uso externo
MX2020004250A (es) Composicion farmaceutica de liberacion sostenida.
UY37867A (es) Formulación de uso tópico para el control y la prevención de parásitos en animales
BR112019001082A2 (pt) gel intestinal de levodopa e carbidopa e métodos de uso
BR112018008556A2 (pt) ?composições farmacêuticas e métodos para tratar ictiose congênita?
BR112016023737A2 (pt) ?composição agrícola, e, método de condicionamento de água?